Actively Recruiting
High Flow Nasal Cannula Weaning in Acute Bronchiolitis
Led by Kuopio University Hospital · Updated on 2025-09-03
50
Participants Needed
4
Research Sites
254 weeks
Total Duration
On this page
Sponsors
K
Kuopio University Hospital
Lead Sponsor
C
Central Finland Hospital District
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical study is to compared two different strategies to end high flow nasal cannula treatment in acute bronchiolitis. This study compared the immediate ending of high flow treatment to weaning strategy, in which the flow rate is gradually decreased. The aim is to assess if the immediate ending shortens the hospitalization time and whether it is a safe strategy.
CONDITIONS
Official Title
High Flow Nasal Cannula Weaning in Acute Bronchiolitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinically diagnosed acute bronchiolitis
- High flow nasal cannula treatment has lasted for at least 12 hours
- Measured oxygen saturation of 95% or more on room air
- High flow rate is a maximum of 2 liters per kilogram per minute
- Treating doctor considers the infant suitable to stop high flow therapy
You will not qualify if you...
- Major congenital anomaly of lungs, heart, or diaphragm
- Bacterial pneumonia
- Parents do not give consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Siun Sote
Joensuu, Finland
Actively Recruiting
2
Central Finland Hospital District
Jyväskylä, Finland
Actively Recruiting
3
Kuopio University Hospital
Kuopio, Finland
Actively Recruiting
4
Mikkeli Central Hospital
Mikkeli, Finland
Actively Recruiting
Research Team
I
Ilari Kuitunen, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here